Study on high red blood cell count
Part of Blood & lymphatic, Cancer clinical trials.
This study is for adults with high hemoglobin levels (meaning their blood has too many red blood cells). It aims to learn more about this condition and help guide care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- Your hemoglobin level is 165 or higher (if you are male) or 160 or higher (if you are female).
- You are able to understand and agree to take part in the study.
- You do not have any condition that would prevent you from giving informed consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at people who have higher-than-normal hemoglobin and platelet counts. It aims to better understand the biology behind these blood changes and how they may be related to disease.
This study tests whether lisinopril, a common blood pressure medication, can help lower red blood cell counts in people who have elevated hemoglobin levels. Researchers want to see if this drug could offer a simpler treatment option for this condition.
This study looks at how thick your blood is (blood viscosity) if you have polycythemia, a condition where your body makes too many red blood cells. It aims to understand the relationship between blood thickness and your red blood cell levels.
This study is a “registry,” meaning it collects information about adults with specific types of myeloproliferative neoplasms (MPNs). It helps researchers better understand these diseases and may improve future care.
This study tests whether CPAP therapy (a machine that helps keep your airway open while you sleep) can lower high red blood cell counts in people who have both sleep apnea and polycythemia. It may help reduce the need for other treatments.
This is an observational study that follows people with certain blood disorders. It aims to learn more about how these conditions behave in real life, which can help improve future care.
Hear when a new Polycythemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.